The discussion covers:

 • How the Artera AI platform uses digital biopsy slide analysis with machine learning to predict outcomes and guide treatment decisions.

 • The difference between prognostic risk assessments (likelihood of distant metastasis or mortality) and predictive biomarkers (who benefits from specific therapies like short-term ADT with radiation).

 • Results from landmark studies, including RTOG clinical trials and the STAMPEDE trial, showing how the Artera test can identify patients most likely to benefit from treatments like abiraterone.

 • Practical implications for patients considering active surveillance, radiation, or hormone therapy.

Dr. Chao also answers audience questions about long-term outcomes, use of older pathology slides, PET imaging, and how the test applies in real-world decision-making.

📌 About the Prostate Forum of Orange County

The Prostate Forum of Orange County (PFOC) is a nonprofit, volunteer-run support and education group for men and their families affected by prostate cancer. We host online support groups on the 2nd and 4th Tuesdays of each month, and feature presentations from medical experts on the 4th Thursday of most months. Our goal is to provide reliable information, expert insight, and a welcoming community where patients, survivors, and caregivers can share experiences and learn together.